Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Grade 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05466422
What this trial is testing

MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)

Who this might be right for
Alzheimer Disease
Merck Sharp & Dohme LLC 34
Testing effectiveness (Phase 2)Study completedNCT02423122
What this trial is testing

A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
EIP Pharma Inc 16
Not applicableStudy completedNCT01536756
What this trial is testing

Effectiveness of a Structured Physical Rehabilitation Program for Chinese Patients With Depressive Disorders

Who this might be right for
Depressive Disorders
Kowloon Hospital, Hong Kong 84
Not applicableNot Yet RecruitingNCT06762522
What this trial is testing

Exploring Feasibility, Acceptability and Impact of Using Neurofeedback with Persons with Mild Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment
Queen's University 20
Not applicableStudy completedNCT00945737
What this trial is testing

A Study on the Effects of Soy Protein on Blood Lipids in Men and Women With Mild to Moderate Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Solae, LLC 60
Testing effectiveness (Phase 2)Study completedNCT00914277
What this trial is testing

SAR407899 Single-dose in Treatment of Mild to Moderate Erectile Dysfunction

Who this might be right for
Erectile Dysfunction
Sanofi 24
Post-approval studies (Phase 4)Study completedNCT00333281
What this trial is testing

Visual Effects of Erectile Dysfunction Medications Dosed Daily for Six Months

Who this might be right for
Erectile Dysfunction
Eli Lilly and Company 198
Post-approval studies (Phase 4)Ended earlyNCT03539601
What this trial is testing

Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD

Who this might be right for
Atopic Dermatitis
Pfizer 237
Large-scale testing (Phase 3)Study completedNCT00667992
What this trial is testing

Study Comparing Budesonide Hydrofluoroalkane (HFA) vs Chlorofluorocarbon (CFC) Pressurized Metered Dose Inhalers (pMDI) in Patients With Mild to Moderate Asthma

Who this might be right for
Asthma
AstraZeneca 99
Early research (Phase 1)Study completedNCT06582264
What this trial is testing

A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Microbiotica Ltd 29
Large-scale testing (Phase 3)Study completedNCT00285012
What this trial is testing

Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).

Who this might be right for
Smoking Cessation
Pfizer 504
Testing effectiveness (Phase 2)Ended earlyNCT00947011
What this trial is testing

Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)

Who this might be right for
Glucose Homeostasis
Johns Hopkins University 12
Not applicableUnknownNCT04045483
What this trial is testing

Virtual Reality Based Cognitive Training Program in Mild Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment
Inha University Hospital 30
Not applicableLooking for participantsNCT06292741
What this trial is testing

Autonomic Involvement in Patient With Cognitive Decline

Who this might be right for
Dementia, MildDementia of Alzheimer Type
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT02397083
What this trial is testing

Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer

Who this might be right for
Atypical Endometrial HyperplasiaFIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid Adenocarcinoma
M.D. Anderson Cancer Center 102
Post-approval studies (Phase 4)WithdrawnNCT01822951
What this trial is testing

Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)

Who this might be right for
Alzheimer Disease
Ever Neuro Pharma GmbH
Testing effectiveness (Phase 2)Study completedNCT01838694
What this trial is testing

Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.

Who this might be right for
Lupus Erythematosus, Systemic
Invion, Inc. 30
Early research (Phase 1)Ended earlyNCT01769222
What this trial is testing

Ipilimumab and Local Radiation for Selected Solid Tumors

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Stanford University 3
Not applicableStudy completedNCT06644131
What this trial is testing

Creatine Monohydrate for Mild Traumatic Brain Injury: a Randomised Controlled Pilot Study

Who this might be right for
Mild Traumatic Brain InjuryConcussion (Diagnosis)
University of Southern Denmark 34
Testing effectiveness (Phase 2)Study completedNCT00002657
What this trial is testing

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
SWOG Cancer Research Network 20
Next Page